Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role of LRRK2 variant p.Gly2019Ser in patients with Parkinsonism.

The Indian journal of medical research - 1 Jun 2020

Sadhukhan Dipanwita, Biswas Arindam, Bhaduri Arunima, Sarkar Neelanjana, Biswas Atanu, Das Shyamal K, Banerjee Tapas K, Ray Kunal, Ray Jharna

Abstract excerpt

Background & objectives: Parkinsonian disorder, including Parkinson's disease (PD), is an aetiologically complex neurodegenerative disorder. Mutations in leucine-rich repeat kinase 2 (LRRK2) gene have been implicated in an autosomal dominant form of PD with variable penetrance. The identification of a common LRRK2 variant (p.Gly2019Ser) in dementia with Lewy bodies indicated its potential role in Parkinsonian...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Predisposition to Disease
Share to History, 16th Century

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Leucine-Rich Repeat Serine-Threonine Protein Kinase-2

Share to Mutation

Share to Parkinson Disease

Share to Penetrance

Source

Open in PubMed Open full text

Identifiers

PMID: 32719233
DOI: 10.4103/ijmr.IJMR_25_18
PMCID: PMC7602925

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of LRRK2 variant p.Gly2019Ser in patients with Parkinsonism.PMID 32719233Read ↗

LRRK2 low-penetrance mutations (Gly2019Ser) and risk alleles (Gly2385Arg)-linking familial and sporadic Parkinson's disease.Semantic proximity Read ↗

Parkinson's Disease: The LRRK2-G2019S mutation: opening a novel era in Parkinson's disease geneticsSemantic proximity Read ↗

LRRK2 in Parkinson's disease: genetic and clinical studies from patients.Semantic proximity Read ↗

Leucine-Rich Repeat Kinase (LRRK2) Genetics and Parkinson's Disease.Semantic proximity Read ↗

The p.Gly2019Ser is the commonest pathogenic mutation in the LRRK2 gene among Egyptians with familial and sporadic Parkinson's diseaseSemantic proximity Read ↗

The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients.Semantic proximity Read ↗

Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study.Semantic proximity Read ↗

An overview of the worldwide distribution of LRRK2 mutations in Parkinson's disease.Semantic proximity Read ↗

Evaluation of the Role of LRRK2 Gene in Parkinson’s Disease in an East Indian CohortSemantic proximity Read ↗

LRRK2 G2019S mutation and Parkinson's disease: a clinical, neuropsychological and neuropsychiatric study in a large Italian sample.Semantic proximity Read ↗

A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease.Semantic proximity Read ↗

Molecular pathogenesis of Parkinson's disease: identification of mutations in the Parkin gene in Indian patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.